Stryker (SYK) Total Debt Growth (3y) (2012 - 2026)
Stryker (SYK) Total Debt Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 24.63% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 4.89% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 11.72% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 0.11% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -0.47% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.01% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -13.48% |
| 10 | Zimmer Biomet Holdings | 19.18 Bn | 18.77 Bn | 1.54 Bn | 9.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.89% |
| Mar 31, 2026 | 4.07% |
| Dec 31, 2025 | 6.72% |
| Sep 30, 2025 | 9.16% |
| Jun 30, 2025 | 7.41% |
| Mar 31, 2025 | 5.98% |
| Dec 31, 2024 | 2.90% |
| Sep 30, 2024 | 6.97% |
| Jun 30, 2024 | -1.37% |
| Mar 31, 2024 | -0.54% |
| Dec 31, 2023 | -2.43% |
| Sep 30, 2023 | -1.12% |
| Jun 30, 2023 | 0.07% |
| Mar 31, 2023 | 7.52% |
| Dec 31, 2022 | 5.57% |
| Sep 30, 2022 | 14.88% |
| Jun 30, 2022 | 16.27% |
| Mar 31, 2022 | 18.51% |
| Dec 31, 2021 | 8.17% |
| Sep 30, 2021 | 20.65% |